Patent ID: 8513389

Claim:
An isolated binding compound that binds to human IL-23, comprising: a) an antibody light chain variable region, or antigen binding fragment thereof, comprising: CDRL1 comprising residues 24-34 of SEQ ID NO: 131; CDRL2 comprising residues 50-56 of SEQ ID NO: 131; CDRL3 comprising residues 89-97 of SEQ ID NO: 131; and b) an antibody heavy chain variable region, or antigen binding fragment thereof, comprising: CDRH1 comprising residues 26-35 of SEQ ID NO: 130; CDRH2 comprising residues 50-66 of a sequence selected from the group consisting of SEQ ID NOs: 99, 129 and 130; and CDRH3 comprising residues 99-104 of SEQ ID NO: 130.